Sterling
Moderna logo
Moderna
CSL logo
CSL

Revenue Comparison

Chart: Revenue Comparison. Values in USD billions. In Q2 2026: Moderna 0.145, CSL 3.6525.

* CSL reports semi-annually. Values are evenly split across both quarters within each half.

Moderna vs CSL Net Worth and Market Cap

Moderna (MRNA) and CSL (CSL.AX) are peers in Vaccines. Moderna reported revenue of $145M as of Q2 2026, compared with $7.3B for CSL. CSL leads on revenue.

Moderna's gross margin is 35.9% versus 44.4% for CSL. Moderna's net margin is -539.3% versus -40.2% for CSL.

Key differences

  • Revenue growth from Q2 2025 to Q2 2026: Moderna +2.1%, CSL +0.7%.
  • CSL made an operating profit in its latest quarter (19.0% margin); Moderna made an operating loss (-562.1%).
  • Moderna's KPIs on Sterling include Cash, Cash Equivalents and Investments (Quarterly) and Net Product Sales vs Deferred Revenue (Quarterly).
  • CSL's KPIs on Sterling include Behring Revenue by Therapy (Annual) and Behring IVIG vs SCIG Revenue (Annual).

Latest Quarter Comparison

Table: Latest Quarter Comparison. 15 rows across Metric, Moderna, CSL.
MetricModernaCSL
Market Cap--
Revenue$145.00M$7.30B
Cost of Revenue$93.00M$4.06B
Gross Profit$52.00M$3.24B
Operating Income$-815.00M$1.39B
Net Income$-782.00M$-2.94B
R&D Expense$651.00M$614.00M
Earnings Per Share-$1.96-$6.14
Gross Margin35.9%44.4%
Operating Margin-562.1%19.0%
Net Profit Margin-539.3%-40.2%
Free Cash Flow$-563.00M$1.76B
Cumulative Free Cash Flow$7.37B$21.56B
Operating Cash Flow$-526.00M$2.09B
Cash & Equivalents$1.72B$1.51B

Ask Sterling

Register for a premium account to gain access to Sterling AI.

Get Started

Things you can ask Sterling:

Summarize Tesla's latest earnings reportWhy did NVIDIA's margins expand?Compare Apple vs Microsoft's cash flowWhat's driving EV industry growth?
Menu
Favorites